Healthcare Asia Summit - April 9, 2025
Register Now
Sponsors & Exhibitors
Overview Healthcare Asia Summit 2025
As the healthcare landscape evolves with rapid advancements in technology and patient care, Healthcare Asia presents the Healthcare Asia Summit 2025 to explore how these advancements can enhance patient care and operational efficiency across the region.
Under the theme of "Future-Proofing Healthcare: Innovations, AI, and Patient-Centric Solutions in Asia," the summit will serve as a platform for insightful discussions on value-based care, healthcare financing, and the role of technological advancements in healthcare across Asia, amongst other key topics.
Join us on 9 April 2025 and gain valuable insights on how these advancements will enhance your understanding of healthcare innovations and patient-centric approaches. Stay tuned and be at the forefront of shaping the future of healthcare in Asia.
Venue: Grand Ballroom 2, 1st Floor, Renaissance Kuala Lumpur Hotel & Convention Centre
Why the Healthcare Asia Summit 2025 is Unmissable:
CONNECT
Engage with healthcare leaders and innovators from across Asia. Build meaningful partnerships and exchange ideas during interactive sessions and panel discussions.
INNOVATE
Discover the latest advancements in AI and patient-centric technologies. Gain actionable insights to enhance operational efficiency and deliver superior patient care.
SPEAKERS
Anastasia Miros
Healthcare and Life Sciences Director
KPMG Asia Pacific
Healthcare and Life Sciences Director
KPMG Asia Pacific
Lim Ren Jun
Principal
Baker McKenzie
Principal
Baker McKenzie
Ren Jun Lim is a Principal of Baker McKenzie Wong & Leow’s Intellectual Property & Technology (IPTech) practice group, and also co-leads the Firm’s Healthcare industry group. He represents local and international clients in both contentious and non-contentious intellectual property and technology matters.
Ren Jun keenly advises on a full range of issues relating to the healthcare industry. These include regulatory compliance in respect of digital healthcare, telemedicine, drugs, medical devices, health supplements, food products, and cosmetics; clinical trials; product liability/recall issues; data exclusivity; patent linkage; competition; and anti-corruption issues.
SPONSORS
AGENDA
8:30 - 9:00 AM REGISTRATION
9:05 - 9:10 AM WELCOME REMARKS
- Tim Charlton, Publisher, Healthcare Asia
9:10 - 9:25 AM Opening Speaker
9:25 - 9:45 AM Keynote Speaker
9:45 - 10:05 AM CEO Fireside Chat
10:05 - 10:35 AM Panel Session 1
10:35 - 11:05 AM NETWORKING - MORNING TEA BREAK
11:05 - 11:25 AM Speaking Session 4
- Anastasia Miros, Healthcare and Life Sciences Director, KPMG Asia Pacific
11:25 - 11:45 AM Speaking Session 5
11:45 - 12:05 PM Speaking Session 6
12:05 - 12:35 PM Panel Discussion 2
12:35 - 2:00 PM MIDDAY BREAK
2:00 - 2:20 PM Speaking Session 7
2:20 - 2:40 PM Speaking Session 8
2:40 - 3:00 PM Speaking Session 9: AI & Data: Opportunities & Pitfalls
- Lim Ren Jun, Principal, Baker McKenzie
3:00 - 3:30 PM NETWORKING - AFTERNOON TEA BREAK
3:30 - 3:50 PM Speaking Session 10
3:50 - 4:10 PM Speaking Session 11
4:10 - 4:40 PM Panel Discussion 3
5:00 PM END OF PROGRAM
Healthcare Asia Summit
For more details, contact:
Healthcare Asia Summit Events Team
+65 31581386
SPEAKERS
Anastasia Miros
Healthcare and Life Sciences Director
KPMG Asia Pacific
Healthcare and Life Sciences Director
KPMG Asia Pacific
Lim Ren Jun
Principal
Baker McKenzie
Principal
Baker McKenzie
Ren Jun Lim is a Principal of Baker McKenzie Wong & Leow’s Intellectual Property & Technology (IPTech) practice group, and also co-leads the Firm’s Healthcare industry group. He represents local and international clients in both contentious and non-contentious intellectual property and technology matters.
Ren Jun keenly advises on a full range of issues relating to the healthcare industry. These include regulatory compliance in respect of digital healthcare, telemedicine, drugs, medical devices, health supplements, food products, and cosmetics; clinical trials; product liability/recall issues; data exclusivity; patent linkage; competition; and anti-corruption issues.